NCT06950385

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2025-07-18Est. Completion: 2030-07

Enrollment target: 168 participants

Locations

City of Hope, Arcadia, California, United States
Yale Cancer Center, New Haven, Connecticut, United States
Georgetown University, Washington D.C., District of Columbia, United States
Digestive & Liver Center of Florida, Orlando, Florida, United States
Cleveland Clinic Florida, Weston, Florida, United States
University of Chicago, Chicago, Illinois, United States
University of Kansas Medical Center, Kansas City, Kansas, United States
Johns Hopkins University, Baltimore, Maryland, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
University of Michigan, Ann Arbor, Michigan, United States
Department of Surgery, Section of Colon Rectal and Surgery, St Louis, Missouri, United States
Cleveland Clinic, Cleveland, Ohio, United States
Ohio State University, Columbus, Ohio, United States
Geisinger Medical Center, Danville, Pennsylvania, United States
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Familial Adenomatous Polyposis

This study reviews post study clinical endoscopy reports in follow up to patients who participated in MAY2016-07-01 with…

Rochester, United StatesCompleted Oct 28, 2021

Familial Adenomatous Polyposis

This is a multicenter, two-part trial in participants with FAP.

Scottsdale, United StatesEst. completion Jun 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.